124 related articles for article (PubMed ID: 38035921)
21. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil.
Harada PH; Bensenõr IJM; Drager LF; Goulart AC; Mill JG; Lotufo PA
Atherosclerosis; 2019 May; 284():59-65. PubMed ID: 30875494
[TBL] [Abstract][Full Text] [Related]
22. Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease.
Singh A; Kumar MS; Jaryal AK; Ranjan P; Deepak KK; Sharma S; Lakshmy R; Pandey RM; Vikram NK
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):956-961. PubMed ID: 28471821
[TBL] [Abstract][Full Text] [Related]
23. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
24. Correlation of ankle-wrist pressure index with ankle-brachial pressure index to assess lower limb perfusion in diabetic foot ulcer: a pilot study.
Roshan R; Chaudhary N; Chouhan U; Huda F; Basu S
J Wound Care; 2024 Jul; 33(7):519-525. PubMed ID: 38967344
[TBL] [Abstract][Full Text] [Related]
25. Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease.
Li X; Shi H; Wang Z; Chang L; Zhang M; Dong X
J Hypertens; 2017 Jun; 35(6):1226-1234. PubMed ID: 28441694
[TBL] [Abstract][Full Text] [Related]
26. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
[TBL] [Abstract][Full Text] [Related]
27. New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study.
Wang J; Liu S; Cao Q; Wu S; Niu J; Zheng R; Bie L; Xin Z; Zhu Y; Wang S; Lin H; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Xu Y; Li M; Bi Y; Zhao Z
Front Med; 2022 Oct; 16(5):714-722. PubMed ID: 35507246
[TBL] [Abstract][Full Text] [Related]
28. The relationship between arterial stiffness and nonalcoholic fatty liver disease.
Lee YJ; Shim JY; Moon BS; Shin YH; Jung DH; Lee JH; Lee HR
Dig Dis Sci; 2012 Jan; 57(1):196-203. PubMed ID: 21750929
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
30. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals.
Kim BJ; Kim NH; Kim BS; Kang JH
Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index.
Chung GE; Choi SY; Kim D; Kwak MS; Park HE; Kim MK; Yim JY
Medicine (Baltimore); 2015 Mar; 94(12):e654. PubMed ID: 25816034
[TBL] [Abstract][Full Text] [Related]
32. Influence of MAFLD and NAFLD on arterial stiffness: A longitudinal cohort study.
Yoo TK; Lee SW; Lee MY; Choi H; Sung KC
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1769-1778. PubMed ID: 38644081
[TBL] [Abstract][Full Text] [Related]
33. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
34. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
[TBL] [Abstract][Full Text] [Related]
35. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults.
Liu Y; Liu C; Shi X; Lin M; Yan B; Zeng X; Chen N; Lu S; Liu S; Yang S; Li X; Li Z
J Diabetes; 2017 Jun; 9(6):586-595. PubMed ID: 27371101
[TBL] [Abstract][Full Text] [Related]
36. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
[TBL] [Abstract][Full Text] [Related]
37. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
[TBL] [Abstract][Full Text] [Related]
39. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
Sagar A; L R; Farheen SA
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
[TBL] [Abstract][Full Text] [Related]
40. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry.
Zahner GJ; Gruendl MA; Spaulding KA; Schaller MS; Hills NK; Gasper WJ; Grenon SM
J Vasc Surg; 2017 Nov; 66(5):1518-1526. PubMed ID: 28756044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
